# OnCo record paper-raghav-atezolizumab-bevacizumab-peritoneal-mesothelioma-cancer-discov-2021 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-raghav-atezolizumab-bevacizumab-peritoneal-mesothelioma-cancer-discov-2021/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-raghav-atezolizumab-bevacizumab-peritoneal-mesothelioma-cancer-discov-2021" ;
  schema:name "Atezolizumab plus bevacizumab in advanced malignant peritoneal mesothelioma"@en ;
  schema:description "In a small trial combining PD-L1 and VEGF blockade, four in ten patients with previously treated peritoneal mesothelioma responded, with responses lasting well over a year, the first dedicated prospective evidence for immunotherapy in this rare disease."@en ;
  schema:url <https://onco.cc/key-papers/paper-raghav-atezolizumab-bevacizumab-peritoneal-mesothelioma-cancer-discov-2021/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1158/2159-8290.CD-21-0331>, <https://pubmed.ncbi.nlm.nih.gov/34261675/> ;
  schema:sameAs <https://doi.org/10.1158/2159-8290.CD-21-0331> ;
  schema:datePublished "2021"^^xsd:gYear ;
  schema:author "Raghav K, Liu S, Overman MJ, et al." ;
  onco:cancers <https://onco.cc/cancers/peritoneal-mesothelioma/> ;
  onco:drugs <https://onco.cc/drugs/atezolizumab/>, <https://onco.cc/drugs/bevacizumab/> ;
  onco:journals <https://onco.cc/journals/cancer-discovery/> .